Orient Pharma

友霖生技醫藥股份有限公司 · 4166

What it does

Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.

Orient Pharma develops, manufactures, and sells western medicines and medical devices, focusing on proprietary products such as central nervous system (CNS) drugs, lipid-lowering drugs, antibiotic drugs, and diabetes drugs.^[1]

The company also undertakes contract manufacturing and product development services commissioned by other companies.^[2]

Utilizing its vertically integrated core capabilities in development, manufacturing, and marketing, Orient Pharma develops 505(b)(2) new drugs with new therapeutic indications and novel combinations to expand into international markets.^[2]

Monthly revenue

Latest month	Revenue	Year on year	Month on month
2026-10	NT$148m	-1.3%	-0.5%

2024-11 to 2026-10, monthly revenue.

Foreign investors

Last 20 trading days	Net
2026-10-12 to 2026-11-10	−NT$5m

Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.

Facts

Full English name	Orient Pharma Co., Ltd.
Chinese name	友霖生技醫藥股份有限公司
Stock code	4166 (TPEx)
Industry	Biotech & medical
Founded	01 Feb 2008
Listed	21 Aug 2025
Paid-in capital	NT$2.4bn
Chairman	蔡正弘
President	黃春桐
Headquarters	12F., No. 128, Sec. 6, Chengde Rd., Beitou Dist., Taipei City ,112052 Taiwan (ROC)
Website	https://academy.oppharma.com/
Official business description	西藥研發、製造及銷售

Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.

Sources

MOPS 公司基本資料友霖生技醫藥股份有限公司 · mops · retrieved 04 Nov 2026
Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026

The Week in Taiwan Companies · free, every Friday
Using it at work? Join the team-plan waiting list